SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-008530
Filing Date
2024-01-30
Accepted
2024-01-30 07:15:32
Documents
23
Period of Report
2024-01-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20240130.htm   iXBRL 8-K 55632
2 EX-99.1 itrm-ex99_1.htm EX-99.1 42637
3 EX-99.2 itrm-ex99_2.htm EX-99.2 10440
4 GRAPHIC itrm-ex99_2s1.jpg GRAPHIC 200948
5 GRAPHIC itrm-ex99_2s2.jpg GRAPHIC 1004796
6 GRAPHIC itrm-ex99_2s3.jpg GRAPHIC 374171
7 GRAPHIC itrm-ex99_2s4.jpg GRAPHIC 326856
8 GRAPHIC itrm-ex99_2s5.jpg GRAPHIC 466184
9 GRAPHIC itrm-ex99_2s6.jpg GRAPHIC 333100
10 GRAPHIC itrm-ex99_2s7.jpg GRAPHIC 335394
11 GRAPHIC itrm-ex99_2s8.jpg GRAPHIC 444051
12 GRAPHIC itrm-ex99_2s9.jpg GRAPHIC 151467
  Complete submission text file 0000950170-24-008530.txt   5251763

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20240130.xsd EX-101.SCH 26762
24 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20240130_htm.xml XML 4891
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 24575805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)